We analyzed existing research on the prognosis of patients who have had a transient ischemic attack to identify studies that adhere to basic methodological principles and to identify underinvestigated questions. Studies were eligible for analysis if they were published in peer-reviewed journals after 1950, written in English, and included at least 50 patients with transient ischemia. Studies that included patients with stroke were included only if they reported outcome rates separately for the subgroup of patients with transient ischemia. Ail eligible studies were extracted by one investigator who recorded adherence to six key methodological principles. Among 60 eligible studies, 54 were observational cohort studies and six were randomized trials. Adherence to the six methodological principles was as follows: eight studies included an adequate description of diagnostic criteria and of procedures used to assure adherence to the criteria, 54 used appropriate end points, two assembled inception cohorts, 10 included an adequate description of end point surveillance, 22 adequately reported and analyzed censored patients, and 10 included a multivariate analysis for predictive variables. No study adhered to all six principles, but two adhered to the three most important ones (appropriate end points, inception cohort, and adequate reporting and analysis of censored patients). Aspects of prognosis after transient ischemia that have not been completely investigated include the severity of subsequent strokes and methods for estimating the outcome risk for individual patients. We conclude that only a few published investigations on prognosis after transient ischemia are methodologically complete. This finding helps explain why it is difficult to interpret many studies. Further research is needed and should target underinvestigated topics. To document underinvestigated aspects of TLA prognosis and to identify those studies providing the most reliable and accurate information, we conducted a structured appraisal of the scientific quality of existing research. We examined each of 60 published Received December 28, 1990; accepted May 31, 1991. reports for adherence to well-accepted methodological principles that enhance the applicability, accuracy, and reproducibiJity of prognosis research.
S ince early studies suggested that patients who have a transient ischemic attack (TIA) are subsequently at high risk for stroke and death, 1 -2 physicians have recognized the need for reliable information on prognosis. Investigators need the information for risk stratification in trials, and clinicians need it for counseling and managing patients. Unfortunately, more recent studies have not always improved on the earlier ones. Many aspects of TLA prognosis that were not investigated in early studies remain unexplored by newer ones.
To document underinvestigated aspects of TLA prognosis and to identify those studies providing the most reliable and accurate information, we conducted a structured appraisal of the scientific quality of existing research. We examined each of 60 published reports for adherence to well-accepted methodological principles that enhance the applicability, accuracy, and reproducibiJity of prognosis research.
Methods
To be included in our analysis, a study had to 1) be published after 1950 in English, 2) include more than 50 TLA patients, 3) cite the exact number of TTA patients enrolled, 4) indicate the interval over which outcome was measured, and 5) report the occurrence of any clinical end point (e.g., TTA, stroke, myocardial infarction, functional status, death). Studies were eligible without consideration of research design or purpose so that randomized and nonrandomized trials of therapy were considered in addition to studies specifically about prognosis.
Investigations that included patients with stroke as well as patients with TTA were eligible only if separate prognostic information was reported for the TLA subgroup.
To give this review broad applicability, we included studies on patients with ischemic symptoms lasting <24 hours and occurring in any vascular distribution. When investigators did not specify the duration of symptoms but used any of the common terms for TIA (i.e., transient monocular blindness, amaurosis fugax, transient cerebral ischemia, vertebrobasilar insufficiency, etc.), we assumed the duration was short enough.
Citations of eligible studies were located from four sources: 1) a MEDLINE (National Library of Medicine MEDLARS Management System) search completed in August 1990, 2) a bibliography on carotid endarterectomy, 3 3) the tables of contents for issues of three journals {Stroke, Neurology, and Annals of Neurology) published during the first 6 months of 1990, and 4) reference lists of eligible articles identified from the preceding sources.
These search techniques yielded 60 studies; 22 61 were randomized trials. Using an extraction form, one of us reviewed the 60 studies for adherence to the methodological principles described below. Studies that included patients with stroke or TIA were evaluated according to their application of the principles to the TLA subgroup. All information was transcribed onto a paper spreadsheet, from which calculations were made.
From methodological guidelines recommended for studying prognosis, 62 - 64 we chose six key principles. The six principles are as follows.
Adequate Description of Diagnostic Criteria and Monitoring Procedures
For the results of research on TLA to be evaluated, applied, and confirmed, investigators must indicate who was included in the study by specifying diagnostic criteria and procedures.
Diagnostic criteria for TIA refer to the accepted signs or symptoms and their duration. The diagnosis of TIA is always first considered because a patient reports symptoms. Because signs may persist after symptoms have resolved, 65 however, the decision to confirm the diagnosis by one or the other is important. For example, if an investigator diagnoses TLA by the absence of neurological signs 1 day after the onset of symptoms, then his cohort will exclude some patients who have persistent signs but no symptoms. A different investigator who diagnoses TIA by symptom resolution would include in his cohort patients who were excluded by the previously described investigator. Diagnostic criteria based on the absence of signs are not necessarily better than criteria based on the resolution of symptoms, and signs may be difficult to use because patients often delay seeking medical attention. Regardless of the diagnostic criteria an investigator chooses, however, it is important that he is consistent and avoids using signs in some patients and symptoms in others.
Diagnostic procedures are what investigators do to ensure fulfillment of the diagnostic criteria. Procedures might be administering a questionnaire, interviewing and examining the patient, or extracting the medical record.
In evaluating studies, we required that investigators 1) state whether diagnosis was based on the resolution of signs, symptoms, or both; 2) specify the allowable signs or symptoms; 3) specify the allowable duration; and 4) describe the procedures for ascertaining that the criteria were met. An adequate description of procedures included enough information for readers to know if the diagnostic criteria were uniformly applied to all patients.
Appropriate End Points
Hierarchical Because of these hierarchical relations, the reported occurrence of stroke alone or TLA alone may be misleading. For example, suppose deaths remove many patients in a cohort who might otherwise be at risk for stroke. The low rate of stroke in the cohort would provide false reassurance of a benign prognosis. The same problem arises for reporting recurrent TIAs, except that the risk of TLA can be reduced by both stroke and death.
Accordingly, whenever stroke is reported as an outcome event in observational studies and randomized trials, the occurrence of stroke plus death should also be reported. Similarly, if TIA is reported, the occurrence of TIA plus stroke plus death should be reported as well.
If death is chosen as the outcome event, the problem of hierarchical end points is avoided since no intervening event prohibits death. In this situation, however, investigators must decide whether to report all-cause mortality, cause-specific mortality (e.g., stroke death), or both. Because judgmental decisions are often involved, assigning a cause of death can be biased. For this reason, whenever cause-specific mortality is reported, all-cause mortality should also be reported.
Managing limitations of binary outcome categories.
Binary outcome categories, such as stroke or death versus alive without stroke, are often used for life table and other popular types of analysis. Binary outcomes, however, have an important disadvantage; the "failure" category in a binary scheme usually contains a mixture of events that have unequal importance. For example, because stroke is less important than death, if both are counted as failures, the count will not indicate the ratio of stroke out- comes to deaths nor how these events overlap when some patients with stroke later die. The problem of unequal and overlapping outcomes is easily managed. After reporting frequencies for the binary outcome categories, investigators may list multiple discrete outcomes comprising the spectrum of possibilities. For example, if one binary outcome category is stroke or death and the other is survival without stroke, there are four possible discrete outcomes: event-free survival to the end of follow-up, stroke followed by survival, stroke followed by death, and death without prior stroke. An illustration of the use of both binary and multiple discrete outcome categories was given in the Canadian Cooperative Study Group's report of a trial of aspirin and sulfinpyrazone in threatened stroke. 68 Importance of classifying stroke severity. Whenever stroke is an end point event, the conclusions can be misleading if the resulting functional deficits are not classified according to severity. In particular, because some stroke survivors may have no functional disability, morbidity may be overestimated unless severity is classified.
Criteria for evaluating end points. Table 1 summarizes our criteria for evaluating end point strategies. Although we prefer the nonbinary strategies listed in this table, we recognize that other schemes may be appropriate. We gave full credit for any reasonable alternative.
These criteria do not require the reporting of binary as well as nonbinary outcome categories or stroke severity. Such requirements might have eliminated "incomplete" studies that nevertheless contain important information. We did monitor the use of nonbinary outcomes and the reporting of stroke severity to help us identify underinvestigated aspects of prognosis.
Inception Cohort
To study prognosis, investigators must designate a moment during the course of each patient's illness from which to measure survival or event-free survival. This moment is often referred to as zero time. 69 Candidate zero times for a cohort of TIA patients include the time of diagnosis, referral to an investigator, or initiation of therapy. An inception cohort 69 is a group of patients for whom the same event demarcates zero time and for whom zero time occurs in the same secular (calendar) era and in the same practice setting. The features and advantages of an inception cohort are further described below.
The purpose of having zero time occur in the same practice setting is to prevent referral bias. This bias can arise when cohorts assembled at teaching hospitals include atypical or unusually sick patients who have been referred from other hospitals. For example, if zero time in a hospital-based inception cohort is the date of TIA diagnosis, a patient who was diagnosed elsewhere and then referred to the study hospital(s) would be excluded. The practice setting might be a single hospital, a group of hospitals, or an entire geographic region.
The purpose of having zero time be the same event for each patient is to assure comparability among patients and to demarcate the pertinent group for applying the results. The zero time event, furthermore, should occur at about the same time after the onset of each patient's TIA symptoms. Mixing patients whose zero time event occurs early after a TIA with patients whose event occurs late may lead to uninterpretable results if prognosis changes over time.
There are two important advantages to zero time that occurs soon after a TLA. First, in addition to being the time from which survival is measured, zero time is also when a patient is usually interviewed and classified according to baseline features. A patient's recall for details about a recent TLA will be better than about a remote one. Second, by using an early zero time an investigator may observe early outcomes. To use an early zero time, investigators must simply require that the zero time event (e.g., diagnosis or referral to the investigator) occur within a specified interval after the TLA; a patient whose event occurs beyond the interval is excluded from study.
The purpose of requiring zero time to occur during the same calendar era for the inception cohort is to minimize the effects of secular changes in diagnostic or therapeutic practice.
For this report, we identified an inception cohort if a clearly defined zero time occurred at a similar point during the course of each patient's illness. We also required that zero time occur in a similar secular era and practice setting for each patient. A similar secular time was defined as within the same 10-year interval. We did not require that zero time occur early after the TIA, but we monitored the use of early zero times as part of our search for underinvestigated topics.
Adequate Description of End Point Surveillance
To determine if a surveillance strategy was adequate to detect all end points, readers must know exactly how surveillance was conducted. Pertinent features include 1) the identity of people responsible for surveillance, 2) the sources of their information, and 3) how these sources were combined. Suitable identification is necessary for readers to judge if the responsible people were both competent and objective. The identification of end point sources and a description of how the sources were combined is necessary because different end point sources are not always equally reliable. Candidate sources include telephone calls and written correspondence to patients, medical records, government data bases, personal physicians, and direct patient examination. Readers of a study may have difficulty judging the relative reliability of its sources, but a judgment is nevertheless necessary for interpreting the results.
For prognosis studies, as for therapeutic trials, it is necessary to guard against bias in surveillance for outcomes. Surveillance bias occurs when a researcher believes a clinical feature (e.g., diabetes) carries a high risk for a specific outcome (e.g., stroke) and differentially interprets or detects outcomes in compared groups with and without the feature. 70 In trials, surveillance bias is prevented by blinding the investigators to treatment. In prognosis studies, blinding is not always practical because the patients are often directly under the care of the investigators; a caregiver usually needs to know a patient's status for diabetes, heart disease, and other variables that are commonly thought to affect outcome. When blinding is not practical, other ways to prevent surveillance bias include objective diagnostic criteria for baseline features and end points, standard surveillance protocols, and external adjudicators for validating end point data.
For this review, the description of a surveillance strategy was rated adequate if it included 1) the identity of study personnel, 2) sources of end point information, and 3) how the sources were combined.
Studies received full credit on this methodological principle for adequately describing the surveillance strategy regardless of the quality of that strategy. We realize that different strategies may be more or less successful in achieving complete and unbiased ascertainment of end points. Evaluating strategies is often difficult, however, and the quality criteria we adopt might be controversial. To identify underinvestigated aspects of TIA prognosis, we tabulated efforts to reduce surveillance bias.
Adequate Reporting and Analysis for Censored Patients
If each member of a cohort is observed for the same length of time, with no dropouts, the proportion of patients who develop the end point is a good measure of risk. For example, if 10 of 100 original TIA patients are dead after 5 years of observation and the other 90 are known to be alive, the death rate is 10% (10/100).
A problem occurs when durations of observation are nonuniform. Nonuniform durations can occur if patients are "censored" for one of three reasons: 1) loss to follow-up, 2) removal by a competing event (e.g., an unrelated death or a change in therapy), or 3) end of the study before the patient has been observed for the desired amount of time. Whatever the reason, censoring makes the denominator of the incidence rate contain patients whose fate is unknown or who are otherwise not at risk to enter the numerator.
When censoring occurs, one analytic policy is to remove all censored patients from the cohort. The end point rates are then calculated only for patients observed for the entire duration of the follow-up period. This policy is not recommended because it fails to use partial follow-up data and may produce inaccurate or biased results. Another option is to convert the incidence rate denominators from "counted persons" into "summed person-durations. 70 " The preferred policy today is to use life table analysis. 70 This method not only allows information for censored patients to be used up to the time of censoring, but also (unlike person-durations) can show how the risk of an end point changes over time.
Of the three sources of censoring, loss to follow-up is the most likely to bias results because there is often a high incidence of end point events (e.g., death) among lost patients. Because life table analysis will not eliminate the bias arising from censoring, readers who want to appraise both the appropriateness and the reliability of end point analysis must know both the number of patients censored and the reasons for their censoring.
We rated a study adequate if the investigator quantified and explained all censored patients. When censoring occurred, we also required life table analysis or person-duration analysis for making use of partial follow-up data.
Multivariate Analysis of Predictive Variables
The term multivariate analysis is used for an examination of the simultaneous relation between a target outcome variable and two or more independent variables. In prognosis research, a prime purpose of multivariate analysis is to check whether independent variables that seem to be important predictors remain important in the presence of other independent variables.
Other important purposes of multivariate analysis are to identify significant combinations of predictors and to construct prediction "instruments" for clinical and research use. These instruments usually identify distinct groups of patients with increasing risk of an outcome event. Useful examples of such instruments have appeared in cardiology, 71 76 as well as in neurology. 77 Multivariate analytic procedures can be as mathematically complex as logistic regression 78 or as simple as tabulations showing outcome rates for patients with none, one, and both of two predictive features.
In evaluating individual studies, we gave credit for the use of any multivariate analysis, regardless of its mathematical structure or formulation, as long as the simultaneous relation between a target outcome variable and two or more independent variables was examined. These criteria for an adequate multivariate analysis are deliberately less stringent than earlier recommendations 79 because we did not want to exclude marginal studies that might contain useful, although not definitive, information. To identify underinvestigated topics, we searched each eligible study for efforts to develop a system for estimating outcome risk for individual patients.
Results

Adherence to Individual Principles
Adequate description of diagnostic criteria and monitoring procedures. Thirty-two studies indicated that TIA was diagnosed by signs (0 studies), symptoms (18 studies), or both (14 studies). Twenty-six studies specified the actual signs or symptoms (some by referencing published diagnostic criteria), 38 specified the allowable duration, and 15 adequately described how patients were monitored for fulfillment of the diagnostic criteria. Only eight studies 60 Because signs often outlast symptoms, it is probably desirable to examine patients at similar times after the onset of symptoms to assure uniformity in diagnostic classification.
No investigators required that their patients be examined ^24 hours after the onset of symptoms. As a result, some studies probably included patients with deficits lasting for >24 hours. We describe this probability to indicate one consequence of current diagnostic practices in TIA research, not because we believe that all investigators should require an early physical examination. The requirement for an early examination would impose a substantial burden on investigators of an illness for which patients often delay seeking medical care.
In summary, most investigators did not state their criteria for diagnosing a TLA, and even fewer indicated how the criteria were monitored. When diagnostic criteria for TIA included the absence of neurological signs, it was not always apparent that all f these also located zero time at the same point after the onset of each patient's TIA. The most common zero time was the date of the first TIA (11 studies); other choices were time of the initial diagnosis, start of therapy, randomization, and notification to investigators. When zero time was not the date of the TLA, investigators for these 18 studies assured that zero time occurred at a uniform time after the onset of symptoms by demanding that the zero time event occur within a circumscribed interval after the TIA, usually <3 months.
Among the 18 studies with a defined, uniform zero time, only two 26 -47 also required that zero time occur during the same 10-year interval and in the same practice setting. Only these two studies, therefore, qualify as having inception cohorts. Zero time for these two studies occurred a median of 3 days after a first TLA.
If we eliminate the requirement that zero time occur during the same decade, seven studies 49 of these would still be disqualified because of specific problems in the assignment of zero time. In each of the four, zero time was the date of the first TIA, even though some patients had not come under observation until weeks or years after this date. This method 80 Outcome rate underestimation in studies like Adherence to the six methodological principles is these (in which some patients come under observation summarized in Table 3 . None of the 60 studies after the desired zero time) can be avoided by using a adhered to aU six principles. technique known as left-censorship."* After eliminaTo identify possfcly superior studies, we relaxed our tion of these four studies, three 4 -*--" meet the relaxed ^l e c t t T°n c n t e n a by eliminating three of the pnncicriteria for having an inception cohort.
f'^ I f w e ,f s t u ( f y i r e g a m u l t i v^a t e a n a t y s i t h r e e the 601 studies, 11 identified the personnel responsible p r i n c i p l e s r e m a i n : a n i n c e p t i o n ^^ adequate refor end point surveillance, 35 identified sources for end portiag a n d a n a l y s i s for ^^^ p a t i e n t S ; a n d appropoint data, and 18 described how the sources were p r i a t e e n d points. Only two reports end point (i.e., death). In two of the nine studies the completely investigated. The methodological princimechanism mcluded blinding techniques. p l e s described are important in facilitating the interAdequate reporting and analysis for censored patients.
pretation and reproducibility of research. Our findThirty-seven of the 60 studies listed the number of ings for nonadherence to the principles help explain censored patients according to the reason for censorwhy it has been difficult to interpret many TIA ship, but only 2VAo-w*&&i&tt&#tAww#-su»fi\ studies and to make comparisons among them, also used life table analysis or a similar technique.
Aspects of TLA prognosis that have not been These 21, therefore, met our criteria for adequate completely investigated include the spectrum of sereporting and analysis for censored patients. Among verity of future strokes and the occurrence of nonbithe 16 studies that listed censored patients but did not nary outcomes. Most importantly, no method has use life table analysis, one 20 reported a very low cenbeen developed for estimating the outcome risk for sorship rate and should be exempted from our requireindividual patients.
The two superior reports 26 - 47 offer an important core of data on prognosis after TTA. Both reports come from the Oxfordshire Community Stroke Project. The findings show that about 6.3% of an original cohort die during each of the 5 years after a first TIA. In contrast, the proportion of an original cohort having a stroke or dying is about 12% during the first year after a TIA and falls to about 6% during years 2 and 3 ( Figure 4 in Reference 47).
Beyond all-cause mortality and stroke or death, the Oxfordshire Community Stroke Project has also published occurrence rates for cause-specific mortality and for the occurrence of myocardial infarction or stroke or death. To the best of our knowledge, the Oxfordshire Community Stroke Project has not yet published a multivariate analysis of predictive variables for TIA patients.
We believe our methodological criteria accurately identified the best-designed studies on TIA prognosis. One study from the Mayo Clinic, 4 however, seemed particularly strong but did not pass our criteria. This study used medical records to identify 289 stroke-free patients examined ^30 days after a first TIA. This study probably had excellent data on short-term survival but failed to meet our methodological criteria because patients were sampled over 24 years and because the number of censored patients was not indicated. We suspect that censoring was minimal and that the study was probably superior.
Publications that did not adhere to our methodological principles should not automatically be judged to have failed in their individual purposes. Twenty-eight of the eligible publications were not designed principally for the study of prognosis (some were clinical trials, others were observational studies of therapeutic outcome); none of these should be expected to include a multivariate analysis for predictive variables. Many eligible publications entered our study because they reported subgroup analyses for patients with TIA; it is probably unreasonable to expect explanations of censoring and multivariate analysis for subgroups. We included trials, other studies of therapy, and studies with subgroups of TIA patients because we suspected that some would contain useful prognostic information for selected TIA patients.
Among the studies we examined, some included only patients with a first TIA and others included patients regardless of whether the TIA was a first episode or recurrence. Some investigators studied TIA as the first manifestation of cerebrovascular disease, and other investigators included patients with a prior stroke. Because patients with a prior TIA or stroke may have a different prognosis from patients without either, we believe that patients with a prior TIA or stroke should probably be analyzed separately.
The results demonstrate a need for more research on TIA prognosis. In particular, the findings of the Oxfordshire Community Stroke Project should be checked in other clinical settings, and new methods are needed for estimating the prognosis for individual patients. We hope that the methodological principles described in this paper will be useful to researchers who design the new studies and to physicians who must interpret them.
